← Back
Data updated: Mar 10, 2026
BIOVAIL LABS INTL
Cardiovascular
BIOVAIL LABS INTL is a specialty pharmaceutical company focused on Cardiovascular.
1988
Since
4
Drugs
-
Trials
47
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CARDIZEM 2025-04-16
Labeling
CITALOPRAM HYDROBROMIDE 2024-12-16
Labeling
CITALOPRAM HYDROBROMIDE 2024-12-16
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-26
Labeling
CITALOPRAM HYDROBROMIDE 2024-11-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1988-02-09
- Latest
- 2007-04-25
- Applications
- 4